FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

Title
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 16, Pages 3586-3590
Publisher
American Association for Cancer Research (AACR)
Online
2015-08-14
DOI
10.1158/1078-0432.ccr-14-2225

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search